Tolerability and efficacy of bimatoprost 0.01 % in patients with open-angle glaucoma or ocular hypertension evaluated in the Taiwanese clinical setting: the Asia Pacific Patterns from Early Access of Lumigan 0.01 % (APPEAL Taiwan) study
Crossref DOI link: https://doi.org/10.1186/s12886-016-0338-6
Published Online: 2016-09-15
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Ying Ying
Wang, Tsing-Hong
Liu, Catherine
Wu, Kwou-Yeung
Chiu, Shin-Lin
Simonyi, Susan
Lu, Da-Wen
Funding for this research was provided by:
Allergan Singapore Pte Ltd
License valid from 2016-09-15